课题基金 / 基金详情

Engineering Enhanced Anti-Apoptosis Activity for Mammalian Cell Culture

Engineering Enhanced Anti-Apoptosis Activity for Mammalian Cell Culture
工程增强哺乳动物细胞培养的抗凋亡活性
批准号:
0001967
负责人:
Michael Betenbaugh
金额:
$57.59万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-15 至 2005-02-28

项目摘要

项目成果

Michael Betenbaugh的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的目标是通过基因工程限制细胞凋亡来增加培养中哺乳动物细胞的寿命。 具体而言,抗凋亡基因将被修饰以防止它们在培养物中降解。 基本原理是生物反应器中的许多哺乳动物细胞死亡是细胞凋亡,因此代表了增加培养物寿命的机制。 这将降低生产成本,并使细胞培养过程适用于更大数量的产品。 本项目将开发稳定的细胞凋亡抑制剂,用于多种哺乳动物宿主,如中国卵巢和婴儿肾脏细胞系。
英文摘要
The objective of this project is to increase the lifetime of mammalian cells in culture by limiting apoptosis through genetic engineering. Specifically, anti-apoptosis genes will be modified to prevent their degradation in culture. The rationale is that much mammalian cell death in bioreactors is apoptotic and therefore represents a mechanism for increasing culture lifetimes. This would reduce productivity costs and make cell culture processes feasible for a larger number of products. This project will develop stable inhibitors for apoptosis for a wide range of mammalian hosts such as Chinese Hamster Ovary and Baby Hamster Kidney cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFRI ELiS: Engineering Fungal Platforms for Sustainable Biomining and Recovery of Valuable Metals from Electronic Wastes
  • 批准号:
    2318122
  • 项目类别:
    Standard Grant
  • 资助金额:
    $200.0万
  • 财政年份:
    2023
  • 负责人:
    Michael Betenbaugh
  • 依托单位:
AccelNet-Implementation: International Biomanufacturing Network (IBioNe)
  • 批准号:
    2114716
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $200.0万
  • 财政年份:
    2021
  • 负责人:
    Michael Betenbaugh
  • 依托单位:
Collaborative Research: GOALI: Dynamic regulation of CHO metabolism to optimize biomanufacturing yields and quality
  • 批准号:
    2035079
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.5万
  • 财政年份:
    2021
  • 负责人:
    Michael Betenbaugh
  • 依托单位:
IUCRC Phase II+: Johns Hopkins University: Advanced Mammalian Biomanufacturing Innovation Center (AMBIC)
  • 批准号:
    2100800
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $130.0万
  • 财政年份:
    2021
  • 负责人:
    Michael Betenbaugh
  • 依托单位:
海外基金